{"id":7840,"date":"2023-05-16T12:51:48","date_gmt":"2023-05-16T09:51:48","guid":{"rendered":"http:\/\/ams.uokerbala.edu.iq\/wp\/en\/?p=7840"},"modified":"2023-05-16T12:59:59","modified_gmt":"2023-05-16T09:59:59","slug":"mutation-in-katg315-is-possibly-a-good-prognostic-marker-for-treatment-with-second-line-drugs-in-multi-drug-resistant-tuberculosis-a-preliminary-study-2","status":"publish","type":"post","link":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/blog\/2023\/05\/16\/mutation-in-katg315-is-possibly-a-good-prognostic-marker-for-treatment-with-second-line-drugs-in-multi-drug-resistant-tuberculosis-a-preliminary-study-2\/","title":{"rendered":"Mutation in katG315 is, possibly, a good prognostic marker for treatment with second-line drugs in multi-drug resistant tuberculosis: A preliminary study"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"7840\" class=\"elementor elementor-7840\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-444a6fa1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"444a6fa1\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-31ff4d84\" data-id=\"31ff4d84\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-30828b82 elementor-widget elementor-widget-heading\" data-id=\"30828b82\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Mutation in katG315 is, possibly, a good prognostic marker for treatment with\nsecond-line drugs in multi-drug resistant tuberculosis: A preliminary study<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-47b02c0e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"47b02c0e\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3648e4e0\" data-id=\"3648e4e0\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-714c835 elementor-widget elementor-widget-spacer\" data-id=\"714c835\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1593435b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1593435b\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-253df7f4\" data-id=\"253df7f4\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3b5772ef elementor-widget elementor-widget-text-editor\" data-id=\"3b5772ef\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5 dir=\"ltr\" style=\"text-align: left;\">Abstract<\/h5><h5 dir=\"ltr\" style=\"text-align: left;\">The aim of this study was to explore baseline data, laboratory and molecular analyses to determine if any could serve<br \/>as potential prognostic marker(s) for treatment response to second line tuberculosis regimens. Of a total number of<br \/>50 multi-drug resistant tuberculosis (MDR-TB) patients starting second-line drug MDR-TB treatment in Iraq, only<br \/>21 showed treatment adherence and thus, included in this study. Response to treatment was monitored for 11 months by<br \/>sputum microscopy and culture. We explored baseline data, laboratory and molecular analyses to determine if any could<br \/>serve as potential prognostic marker(s) for treatment response. Highly signifi cant association (P = 0.019) was detected<br \/>between mutations in katG315 codon and good response to second-line anti-TB drugs. Spoligotyping and mycobacterial<br \/>interspersed repetitive unit variable number tandem repeat confi rmed that katG315-mutatnt isolates were genotypically<br \/>unrelated. The katG315 mutation is a potential prognostic marker for treatment response to second-line anti-tuberculosis<br \/>drugs. One possible explanation of our results is that the katG315-mutants are sensitive to bacterial killing by \u201coxidative<br \/>killing.\u201d<br \/>Key words: KatG315, multi-drug resistant, second-line drugs, tuberculosis<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4524b34a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4524b34a\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-79820fc5\" data-id=\"79820fc5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5dd49677 elementor-widget elementor-widget-button\" data-id=\"5dd49677\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/drive.google.com\/file\/d\/1O2y6a3pi6vLAYk1hV6vPa3FFjwzvsJ9s\/view?usp=sharing\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Read More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Mutation in katG315 is, possibly, a good prognostic marker for treatment with second-line drugs in multi-drug resistant tuberculosis: A preliminary study Abstract The aim of this study was to explore baseline data, laboratory and molecular analyses to determine if any could serveas potential prognostic marker(s) for treatment response to second line tuberculosis regimens. Of a [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ocean_post_layout":"","ocean_both_sidebars_style":"","ocean_both_sidebars_content_width":0,"ocean_both_sidebars_sidebars_width":0,"ocean_sidebar":"","ocean_second_sidebar":"","ocean_disable_margins":"enable","ocean_add_body_class":"","ocean_shortcode_before_top_bar":"","ocean_shortcode_after_top_bar":"","ocean_shortcode_before_header":"","ocean_shortcode_after_header":"","ocean_has_shortcode":"","ocean_shortcode_after_title":"","ocean_shortcode_before_footer_widgets":"","ocean_shortcode_after_footer_widgets":"","ocean_shortcode_before_footer_bottom":"","ocean_shortcode_after_footer_bottom":"","ocean_display_top_bar":"default","ocean_display_header":"default","ocean_header_style":"","ocean_center_header_left_menu":"","ocean_custom_header_template":"","ocean_custom_logo":0,"ocean_custom_retina_logo":0,"ocean_custom_logo_max_width":0,"ocean_custom_logo_tablet_max_width":0,"ocean_custom_logo_mobile_max_width":0,"ocean_custom_logo_max_height":0,"ocean_custom_logo_tablet_max_height":0,"ocean_custom_logo_mobile_max_height":0,"ocean_header_custom_menu":"","ocean_menu_typo_font_family":"","ocean_menu_typo_font_subset":"","ocean_menu_typo_font_size":0,"ocean_menu_typo_font_size_tablet":0,"ocean_menu_typo_font_size_mobile":0,"ocean_menu_typo_font_size_unit":"px","ocean_menu_typo_font_weight":"","ocean_menu_typo_font_weight_tablet":"","ocean_menu_typo_font_weight_mobile":"","ocean_menu_typo_transform":"","ocean_menu_typo_transform_tablet":"","ocean_menu_typo_transform_mobile":"","ocean_menu_typo_line_height":0,"ocean_menu_typo_line_height_tablet":0,"ocean_menu_typo_line_height_mobile":0,"ocean_menu_typo_line_height_unit":"","ocean_menu_typo_spacing":0,"ocean_menu_typo_spacing_tablet":0,"ocean_menu_typo_spacing_mobile":0,"ocean_menu_typo_spacing_unit":"","ocean_menu_link_color":"","ocean_menu_link_color_hover":"","ocean_menu_link_color_active":"","ocean_menu_link_background":"","ocean_menu_link_hover_background":"","ocean_menu_link_active_background":"","ocean_menu_social_links_bg":"","ocean_menu_social_hover_links_bg":"","ocean_menu_social_links_color":"","ocean_menu_social_hover_links_color":"","ocean_disable_title":"default","ocean_disable_heading":"default","ocean_post_title":"","ocean_post_subheading":"","ocean_post_title_style":"","ocean_post_title_background_color":"","ocean_post_title_background":0,"ocean_post_title_bg_image_position":"","ocean_post_title_bg_image_attachment":"","ocean_post_title_bg_image_repeat":"","ocean_post_title_bg_image_size":"","ocean_post_title_height":0,"ocean_post_title_bg_overlay":0.5,"ocean_post_title_bg_overlay_color":"","ocean_disable_breadcrumbs":"default","ocean_breadcrumbs_color":"","ocean_breadcrumbs_separator_color":"","ocean_breadcrumbs_links_color":"","ocean_breadcrumbs_links_hover_color":"","ocean_display_footer_widgets":"default","ocean_display_footer_bottom":"default","ocean_custom_footer_template":"","ocean_post_oembed":"","ocean_post_self_hosted_media":"","ocean_post_video_embed":"","ocean_link_format":"","ocean_link_format_target":"self","ocean_quote_format":"","ocean_quote_format_link":"post","ocean_gallery_link_images":"on","ocean_gallery_id":[],"footnotes":""},"categories":[95],"tags":[],"class_list":["post-7840","post","type-post","status-publish","format-standard","hentry","category-suhad-hadi-mohammed","entry"],"aioseo_notices":[],"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":false,"author_link":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/blog\/author\/ams0manager\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/blog\/category\/research\/suhad-hadi-mohammed\/\" rel=\"category tag\">Suhad Hadi Mohammed<\/a>","rttpg_excerpt":"Mutation in katG315 is, possibly, a good prognostic marker for treatment with second-line drugs in multi-drug resistant tuberculosis: A preliminary study Abstract The aim of this study was to explore baseline data, laboratory and molecular analyses to determine if any could serveas potential prognostic marker(s) for treatment response to second line tuberculosis regimens. Of a&hellip;","_links":{"self":[{"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/posts\/7840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/comments?post=7840"}],"version-history":[{"count":4,"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/posts\/7840\/revisions"}],"predecessor-version":[{"id":7845,"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/posts\/7840\/revisions\/7845"}],"wp:attachment":[{"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/media?parent=7840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/categories?post=7840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ams.uokerbala.edu.iq\/wp\/en\/wp-json\/wp\/v2\/tags?post=7840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}